These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
684 related items for PubMed ID: 12186324
1. Drug use among the urban poor in Kolkata: behaviour and environment correlates of low HIV infection. Panda S, Saha U, Pahari S, Nathan M, Poddar S, Neogi D, Sarkar M, Pal NK, Mahalanabis D. Natl Med J India; 2002; 15(3):128-34. PubMed ID: 12186324 [Abstract] [Full Text] [Related]
2. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur. Sarkar S, Panda S, Sarkar K, Hangzo CZ, Bijaya L, Singh NY, Das N, Agarwal A, Chatterjee A, Deb BC. Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497 [Abstract] [Full Text] [Related]
3. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009. Broz D, Wejnert C, Pham HT, DiNenno E, Heffelfinger JD, Cribbin M, Krishna N, Teshale EH, Paz-Bailey G, National HIV Behavioral Surveillance System Study Group. MMWR Surveill Summ; 2014 Jul 04; 63(6):1-51. PubMed ID: 24990587 [Abstract] [Full Text] [Related]
4. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey. Johnston L, Saumtally A, Corceal S, Mahadoo I, Oodally F. Int J Drug Policy; 2011 Jul 04; 22(4):252-8. PubMed ID: 21700442 [Abstract] [Full Text] [Related]
6. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Rhodes T, Platt L, Maximova S, Koshkina E, Latishevskaya N, Hickman M, Renton A, Bobrova N, McDonald T, Parry JV. Addiction; 2006 Feb 04; 101(2):252-66. PubMed ID: 16445554 [Abstract] [Full Text] [Related]
8. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India. Mahanta J, Medhi GK, Paranjape RS, Roy N, Kohli A, Akoijam BS, Dzuvichu B, Das HK, Goswami P, Thongamba G, IBBA study team. AIDS; 2008 Dec 04; 22 Suppl 5():S59-68. PubMed ID: 19098480 [Abstract] [Full Text] [Related]
9. HIV prevalence and factors associated with HIV infection among male injection drug users under 30: a cross-sectional study in Long An, Vietnam. Tran TM, Nguyen HT, Yatsuya H, Hamajima N, Nishimura A, Ito K. BMC Public Health; 2006 Oct 10; 6():248. PubMed ID: 17029648 [Abstract] [Full Text] [Related]
13. Injection drug use in Calcutta: a potential focus for an explosive HIV epidemic. Panda S, Chatterjee A, Sarkar S, Jalan KN, Maitra T, Mukherjee S, Mukherjee B, Deb BC, Abdul-Quader AS. Drug Alcohol Rev; 1997 Mar 10; 16(1):17-23. PubMed ID: 16203407 [Abstract] [Full Text] [Related]
14. Drug abuse in Nepal: a rapid assessment study. Chatterjee A, Uprety L, Chapagain M, Kafle K. Bull Narc; 1996 Mar 10; 48(1-2):11-33. PubMed ID: 9839033 [Abstract] [Full Text] [Related]
15. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003. Emmanuelli J, Desenclos JC. Addiction; 2005 Nov 10; 100(11):1690-700. PubMed ID: 16277629 [Abstract] [Full Text] [Related]